What factors affect the duration of treatment with diphenylcyclopropenone immunotherapy for common warts?

Dermatol Ther. 2018 Nov;31(6):e12740. doi: 10.1111/dth.12740. Epub 2018 Oct 8.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Child
  • Cyclopropanes / administration & dosage*
  • Cyclopropanes / adverse effects
  • Drug Administration Schedule
  • Facial Dermatoses / diagnosis
  • Facial Dermatoses / drug therapy*
  • Facial Dermatoses / immunology
  • Facial Dermatoses / virology
  • Female
  • Humans
  • Immunologic Factors / administration & dosage*
  • Immunologic Factors / adverse effects
  • Immunotherapy / adverse effects
  • Immunotherapy / methods*
  • Male
  • Nail Diseases / diagnosis
  • Nail Diseases / drug therapy*
  • Nail Diseases / immunology
  • Nail Diseases / virology
  • Remission Induction
  • Retrospective Studies
  • Skin / drug effects*
  • Skin / immunology
  • Skin / pathology
  • Skin / virology
  • Time Factors
  • Treatment Outcome
  • Warts / diagnosis
  • Warts / drug therapy*
  • Warts / immunology
  • Warts / virology
  • Young Adult

Substances

  • Cyclopropanes
  • Immunologic Factors
  • diphenylcyclopropenone